SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-263316
Filing Date
2021-09-01
Accepted
2021-09-01 16:50:35
Documents
3
Period of Report
2021-09-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d227068d8k.htm 8-K 23016
2 EX-10.1 d227068dex101.htm EX-10.1 42312
3 EX-99.1 d227068dex991.htm EX-99.1 5342
  Complete submission text file 0001193125-21-263316.txt   71932
Mailing Address 3525 DEL MAR HEIGHTS RD., #332 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #332 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 211230554
SIC: 2834 Pharmaceutical Preparations